Sign in
4

Changes in Ownership

ProQR Therapeutics N.V. Filed Acc 0001104659-26-082890

Chief Executive Officer bought 150,000 shares at $1.74 ($261,000)

From the SEC's structured data for this filing

Trades in this filing

de Boer Daniel Anton · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-09 Purchase : show line 1 in the form +150,000 $1.74 $261,000 300,000 D
Open-market purchases · 150,000 sh · avg $1.74 · $261,000
Loading xslF345X06/tm2620241-1_4seq1.xml…